Bayesian Capital Management’s Equinor EQNR Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
Sell
-7,155
Closed -$302K 253
2026
Q1
$302K Buy
+7,155
New +$216K 0.37% 88
2025
Q1
Sell
-46,500
Closed -$1.1M 714
2024
Q4
$1.1M Buy
+46,500
New +$1.12M 0.13% 218
2024
Q3
Sell
-30,700
Closed -$877K 783
2024
Q2
$877K Buy
+30,700
New +$856K 0.1% 259
2023
Q4
Sell
-34,907
Closed -$1.14M 831
2023
Q3
$1.14M Buy
34,907
+13,200
+61% +$409K 0.13% 193
2023
Q2
$634K Sell
21,707
-29,600
-58% -$843K 0.07% 355
2023
Q1
$1.46M Buy
51,307
+23,000
+81% +$694K 0.18% 165
2022
Q4
$1.01M Buy
+28,307
New +$1.02M 0.15% 178
2020
Q2
Sell
-14,500
Closed -$177K 592
2020
Q1
$177K Buy
+14,500
New +$234K 0.04% 604

Other funds holding EQNR

Bayesian Capital Management's EQNR Position: Q2 2026 in Review

Bayesian Capital Management sold out of Equinor (EQNR) in Q2 2026, closing a stake of 7,155 shares — an estimated $302K sold.

Bayesian Capital Management first reported a position in EQNR in Q1 2020 and held it in 8 quarters. The position peaked at $1.46M in Q1 2023. 412 funds tracked by Wall St. Rank hold EQNR as of Q2 2026.

  • Bayesian Capital Management reported no remaining Equinor position as of Q2 2026 after selling out during the quarter.
  • Bayesian Capital Management sold 7,155 Equinor shares in Q2 2026, an estimated $302K.
  • Bayesian Capital Management first reported a position in Equinor in Q1 2020 and held it in 8 quarters.
  • Bayesian Capital Management's Equinor position peaked at $1.46M in Q1 2023.
  • 412 funds tracked by Wall St. Rank held Equinor as of Q2 2026.

Based on Bayesian Capital Management's 13F filing for Q2 2026, filed 14 Aug 2026.